Home
Home

type 2 diabetes

FDA reviewing heart risks of Glaxo diabetes pill

FDA reviewing heart risks of Glaxo diabetes pill
Yahoo/AP

Repros Gets Additional Patents

Repros Gets Additional Patents
Yahoo/Zacks

FDA OKs first-of-a-kind diabetes drug from J&J

FDA OKs first-of-a-kind diabetes drug from J&J
Yahoo/AP

2 Can't-Miss FDA Rulings Next Week

2 Can't-Miss FDA Rulings Next Week
Motley Fool

4 Key Drug Approvals Expected In The Next 30 Days

4 Key Drug Approvals Expected In The Next 30 Days
investors.com

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Seeking Alpha

Takeda Put Actos Sales Ahead of User Safety, Witness Says

Takeda Put Actos Sales Ahead of User Safety, Witness Says
Bloomberg

Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes

Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes
Yahoo/BusinessWire

How Serious Is This News for Diabetes Drugmakers?

How Serious Is This News for Diabetes Drugmakers?
Motley Fool

Takeda Worried About Actos’s Cancer Link, Filing Shows

Takeda Worried About Actos’s Cancer Link, Filing Shows
BusinessWeek